Failure to induce resistance to cytotoxic drugs in normal lymphocytes

Leukemia Research

Volumn 20, Issue 8, 1996, Pages 645-648

  Bentley, Paul ^a   Thomas, Alun ^a   Thomas, Jose ^a  

^a LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy resistance; Normal lymphocytes

Indexed keywords

CARBOPLATIN; CHLORAMBUCIL; CYTOTOXIC AGENT; ETOPOSIDE;

ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; HUMAN; HUMAN CELL; LUNG CANCER; LYMPHOCYTE; PRIORITY JOURNAL;

EID: 0030221529     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/0145-2126(96)00024-0     Document Type: Article

References (26)

1. 1. Abbaszadegan M. R., Futscher B. W., Klimecki W. T., List A. & Dalton W. S. (1994) Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells. Cancer Res. 54, 4676.
2. 2. Chaudhary P. M., Mechetner E. B. & Roninson I. B. (1992) Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood 80, 2735.
3. 3. Drach D., Zhaos S., Drach J., Mahadevia R., Gattringer C., Huber H. & Andreeff M. (1992) Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood 80, 2729.
4. 4. Klimecki W. T., Futscher B. W., Grogan T. M. & Dalton W. S. (1994) P-Glycoprotein expression and function in circulating blood cells from normal volunteers. Blood 83, 2451.
5. 5. Silber R., Degar B., Costin D., Newcomb E. W., Mani M., Rosenberg C. R., Morse L., Drygas J. C., Canellakis Z. N. & Potmesil M. (1994) Chemosensitivity of lymphocytes from patients with B cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs. Blood 84, 3440.
6. 6. Gekeler V., Frese G., Noller A., Handgretinger R., Wilisch A., Schmidt H., Muller C. P., Dopfer R., Klingebiel T., Diddens H., Probst H. & Niethammer D. (1992) Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias. Br. J. Cancer 66, 507.
7. 7. Sanfilippo O., Ronchi E., De Marco C., Di Fronzo G. & Silvestrini R. (1991) Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristine. Eur. J. Cancer 27, 155.
8. 8. Bentley D. P. & Blackmore J. A. (1992) The inhibition of DNA synthesis in chronic lymphocytic leukaemia cells by chlorambucil in vitro. Br. J. Cancer 65, 171.
9. 9. Chaudhary P. M. & Roninson I. B. (1993) Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J. Natl Cancer Inst. 85, 632.
10. 10. Evans C. D., Mirski S. E., Danks M. K. & Cole S. P. C. (1994) Reduced levels of topoisomerase II alpha and II beta in a multidrug-resistant lung-cancer cell line. Cancer Chemother. Pharmacol. 34, 242.
11. 11. Hasegawa S., Abe T., Naito S., Kotoh S., Kurnazawa J., Hipfner D. R., Deeley R. G., Cole S. P. C. & Kuwano M. (1995) Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines. Br. J. Cancer 71, 907.
12. 12. Herweijer H., Sonneveld P., Bass F. & Nooter K. (1990) Expression of mdr 1 and mdr 3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine. J. Natl Cancer Inst. 82, 1133.
13. 13. Holmes J., Jacobs A., Carter G., Janowska-Wieczorek A. & Padua R. A. (1989) Multidrug resistance in haemopoietic cell lines, myelodysplastic syndromes and acute myeloblastic leukaemia. Br. J. Haematol. 72, 40.
14. 14. Miller T. P., Grogan T. M., Dalton W. S., Spier C. M., Scheper R. J. & Salmon S. E. (1991) P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil. J. Clin. Oncol. 9, 17.
15. 15. Salmon S. E., Grogan T. M., Miller T., Scheper R. & Dalton W. S. (1989) Prediction of Doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by P-glycoprotein staining. J. Natl Cancer Inst. 81, 696.
16. 16. McKenna S. L., Whittaker J. A., Padua R. A. & Holmes J. A. (1993) Topoisomerase II expression in normal haemopoietic cells and chronic lymphocytic leukaemia: drug sensitivity or resistance? Leukemia 7, 1199.
17. 17. Schisselbauer J. C., Silber R., Papadopoulos E., Abrams K., LaCreta F. P. & Tew K. D. (1990) Characterization of glutathione s-transferase expression in lymphocytes from chronic lymphocytic leukemia patients. Cancer Res. 50, 3562.
18. 18. Gupta R. S. (1983) Genetic, biochemical, and cross-resistance studies with mutants of Chinese hamster ovary cells resistant to the anticancer drugs, VM-26 and VP-16-213. Cancer Res. 43, 1568.
19. 19. Pommier Y., Kerrigan D., Schwartz R. E., Swack J. A. & McCurdy A. (1986) Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitors. Cancer Res. 46, 3075.
20. 20. Holmes J. A., Jacobs A., Carter G., Whittaker J. A., Bentley D. P. & Padua R. A. (1990) Is the mdr 1 gene relevant in chronic lymphocytic leukemia? Leukemia 4, 216.
21. 21. Perry R. R., Mazetta J., Levin M. & Barranco S. C. (1993) Glutathione levels and variability in breast tumors and normal tissue. Cancer 72, 783.
22. 22. Szarka C. E., Pfeiffer G. R., Hum S. T., Everley L. C., Balshem A. M., Moore D. F., Litwin S., Goosenberg E. B., Frucht H., Engstrom P. F. & Clapper M. L. (1995) Glutathione s-transferase activity and glutathione s-transferase μ expression in subjects with risk for colorectal cancer. Cancer Res. 55, 2789.
23. 23. Tiirikainen M. I., Elonen E., Syrjälä M. T., Jansson S.-E. & Krusius T. (1994) Flow cytometric analysis of glutathione-s-transferase-π in acute leukemia. Leukemia 8, 978.
24. 24. Hegewisch-Becker S., Szudra A. & Hossfeld D. K. (1993) Exposure to lipophilic industrial solvents leads to increased P-glycoprotein expression in peripheral blood cells. Br. J. Haematol. 85, 220.
25. 6-alkylguanines in the nuclear DNA of human lymphocytes and leukaemic cells: analysis at the single-cell level. Br. J. Cancer 69, 698.
26. 26. Kalken C. van, Pinedo H. M. & Giaccone G. (1991) Multidrug resistance from the clinical point of view. Eur. J. Cancer 27, 1481.